QQQ   309.75 (+1.19%)
AAPL   158.93 (+0.70%)
MSFT   277.66 (+1.97%)
META   204.28 (+2.24%)
GOOGL   105.60 (+2.16%)
AMZN   98.71 (+0.01%)
TSLA   192.22 (+0.56%)
NVDA   271.91 (+2.73%)
NIO   9.27 (+1.98%)
BABA   86.52 (+3.43%)
AMD   100.28 (+2.77%)
T   18.46 (+0.38%)
F   11.42 (-0.52%)
MU   61.34 (+5.45%)
CGC   1.91 (+1.60%)
GE   91.59 (+2.23%)
DIS   95.83 (+0.98%)
AMC   4.47 (+3.00%)
PFE   40.18 (+0.42%)
PYPL   72.56 (-2.39%)
NFLX   320.37 (+9.01%)
QQQ   309.75 (+1.19%)
AAPL   158.93 (+0.70%)
MSFT   277.66 (+1.97%)
META   204.28 (+2.24%)
GOOGL   105.60 (+2.16%)
AMZN   98.71 (+0.01%)
TSLA   192.22 (+0.56%)
NVDA   271.91 (+2.73%)
NIO   9.27 (+1.98%)
BABA   86.52 (+3.43%)
AMD   100.28 (+2.77%)
T   18.46 (+0.38%)
F   11.42 (-0.52%)
MU   61.34 (+5.45%)
CGC   1.91 (+1.60%)
GE   91.59 (+2.23%)
DIS   95.83 (+0.98%)
AMC   4.47 (+3.00%)
PFE   40.18 (+0.42%)
PYPL   72.56 (-2.39%)
NFLX   320.37 (+9.01%)
QQQ   309.75 (+1.19%)
AAPL   158.93 (+0.70%)
MSFT   277.66 (+1.97%)
META   204.28 (+2.24%)
GOOGL   105.60 (+2.16%)
AMZN   98.71 (+0.01%)
TSLA   192.22 (+0.56%)
NVDA   271.91 (+2.73%)
NIO   9.27 (+1.98%)
BABA   86.52 (+3.43%)
AMD   100.28 (+2.77%)
T   18.46 (+0.38%)
F   11.42 (-0.52%)
MU   61.34 (+5.45%)
CGC   1.91 (+1.60%)
GE   91.59 (+2.23%)
DIS   95.83 (+0.98%)
AMC   4.47 (+3.00%)
PFE   40.18 (+0.42%)
PYPL   72.56 (-2.39%)
NFLX   320.37 (+9.01%)
QQQ   309.75 (+1.19%)
AAPL   158.93 (+0.70%)
MSFT   277.66 (+1.97%)
META   204.28 (+2.24%)
GOOGL   105.60 (+2.16%)
AMZN   98.71 (+0.01%)
TSLA   192.22 (+0.56%)
NVDA   271.91 (+2.73%)
NIO   9.27 (+1.98%)
BABA   86.52 (+3.43%)
AMD   100.28 (+2.77%)
T   18.46 (+0.38%)
F   11.42 (-0.52%)
MU   61.34 (+5.45%)
CGC   1.91 (+1.60%)
GE   91.59 (+2.23%)
DIS   95.83 (+0.98%)
AMC   4.47 (+3.00%)
PFE   40.18 (+0.42%)
PYPL   72.56 (-2.39%)
NFLX   320.37 (+9.01%)
LON:APH

Alliance Pharma - APH Price Target & Analyst Ratings

GBX 62
+3.60 (+6.16%)
(As of 03/23/2023 12:00 AM ET)
Add
Compare
Today's Range
58.11
▼
63.02
50-Day Range
57.60
▼
71.70
52-Week Range
34.14
▼
122
Volume
777,209 shs
Average Volume
2.31 million shs
Market Capitalization
£334.80 million
P/E Ratio
3,100.00
Dividend Yield
3.23%
Price Target
GBX 102.50

Alliance Pharma Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Moderate Buy
Based on 4 Analyst Ratings

Consensus Analyst Price Target

GBX 102.50
High PredictionGBX 130
Average PredictionGBX 102.50
Low PredictionGBX 65
TypeCurrent
3/23/22 to 3/23/23		1 Month Ago
2/21/22 to 2/21/23		3 Months Ago
12/23/21 to 12/23/22		1 Year Ago
3/23/21 to 3/23/22
Consensus Rating
Moderate Buy
Buy
Buy
Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
3 Buy rating(s)
3 Buy rating(s)
2 Buy rating(s)
2 Buy rating(s)
Hold
1 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price TargetGBX 102.50GBX 115GBX 137.50GBX 120.50
Get Alliance Pharma Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for APH and its competitors with MarketBeat's FREE daily newsletter.

APH Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

APH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Alliance Pharma Stock vs. The Competition

TypeAlliance PharmaMedical Companies
Consensus Rating Score
2.75
2.64
Consensus RatingModerate BuyBuy
News Sentiment RatingPositive News
Neutral News

Historical Target Prices and Ratings

Export to Excel
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
3/17/2023Peel Hunt
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Initiated CoverageHoldGBX 65+4.67%
2/1/2023Numis Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingBuyGBX 110+75.16%
1/17/2023Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetBuyGBX 110 ➝ GBX 105+73.55%
8/8/2022Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingOutperformGBX 130+37.71%
(Data available from 3/23/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












APH Price Target - Frequently Asked Questions

What is Alliance Pharma's consensus rating and price target?

According to the issued ratings of 4 analysts in the last year, the consensus rating for Alliance Pharma stock is Moderate Buy based on the current 1 hold rating and 3 buy ratings for APH. The average twelve-month price prediction for Alliance Pharma is GBX 102.50 with a high price target of GBX 130 and a low price target of GBX 65. Learn more on APH's analyst rating history.

Do Wall Street analysts like Alliance Pharma more than its competitors?

Analysts like Alliance Pharma more than other Medical companies. The consensus rating for Alliance Pharma is Moderate Buy while the average consensus rating for medical companies is Buy. Learn more on how APH compares to other companies.

Does Alliance Pharma's stock price have much upside?

According to analysts, Alliance Pharma's stock has a predicted upside of 46.53% based on their 12-month price targets.

What analysts cover Alliance Pharma?

Alliance Pharma has been rated by Berenberg Bank, Numis Securities, and Peel Hunt in the past 90 days.


Stock Ratings Reports and Tools

Today's Ratings:
Top Rated Stocks:
More Ratings Tools:
Ratings for Popular Stocks:
This page (LON:APH) was last updated on 3/23/2023 by MarketBeat.com Staff